Monitoring fibril formation of the N-terminal domain of PABPN1 carrying an alanine repeat by tryptophan fluorescence and real-time NMR

FEBS Letters

Volumn 582, Issue 11, 2008, Pages 1587-1592

  Rohrberg, Julia ^a   Sachs, Rolf ^b   Lodderstedt, Grit ^a   Sackewitz, Mirko ^a   Balbach, Jochen ^b   Schwarz, Elisabeth ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b Institute of Physics   (Germany)

Author keywords

Fibril formation; PABPN1; Poly alanine; Real time NMR; Trinucleotide expansion; Tryptophan fluorescence

Indexed keywords

ACRYLAMIDE; ALANINE; BINDING PROTEIN; PROTEIN PABPN1; TRYPTOPHAN DERIVATIVE;

ARTICLE; CONTROLLED STUDY; FIBER; FLUORESCENCE SPECTROSCOPY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTON NUCLEAR MAGNETIC RESONANCE;

ALANINE; AMINO ACID SEQUENCE; AMYLOID; FLUORESCENCE; HUMANS; MOLECULAR SEQUENCE DATA; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; POLY(A)-BINDING PROTEIN II; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT PROTEINS; REPETITIVE SEQUENCES, AMINO ACID; TRYPTOPHAN;

EID: 43049167415     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2008.04.002     Document Type: Article

References (21)

1. Wahle E., and Ruegsegger U. 3′-End processing of pre-mRNA in eukaryotes. FEMS Microbiol. Rev. 23 (1999) 277-295
2. Wahle E. A novel poly(A)-binding protein acts as a specificity factor in the second phase of messenger RNA polyadenylation. Cell 66 (1991) 759-768
3. Tome F.M., Chateau D., Helbling-Leclerc A., and Fardeau M. Morphological changes in muscle fibers in oculopharyngeal muscular dystrophy. Neuromuscul. Disord. 7 Suppl. 1 (1997) S63-S69
4. Tome F.M., and Fardeau M. Nuclear inclusions in oculopharyngeal dystrophy. Acta Neuropathol. (Berl.) 49 (1980) 85-87
5. Calado A., Tome F.M., Brais B., Rouleau G.A., Kuhn U., Wahle E., and Carmo-Fonseca M. Nuclear inclusions in oculopharyngeal muscular dystrophy consist of poly(A) binding protein 2 aggregates which sequester poly(A) RNA. Hum. Mol. Genet. 9 (2000) 2321-2328
6. Uyama E., Tsukahara T., Goto K., Kurano Y., Ogawa M., Kim Y.J., Uchino M., and Arahata K. Nuclear accumulation of expanded PABP2 gene product in oculopharyngeal muscular dystrophy. Muscle Nerve 23 (2000) 1549-1554
7. Brais B., et al. Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy. Nat. Genet. 18 (1998) 164-167
8. Scheuermann T., Schulz B., Blume A., Wahle E., Rudolph R., and Schwarz E. Trinucleotide expansions leading to an extended poly-l-alanine segment in the poly (A) binding protein PABPN1 cause fibril formation. Protein Sci. 12 (2003) 2685-2692
9. Lodderstedt G., Hess S., Hause G., Scheuermann T., Scheibel T., and Schwarz E. Effect of oculopharyngeal muscular dystrophy-associated extension of seven alanines on the fibrillation properties of the N-terminal domain of PABPN1. FEBS J. 274 (2007) 346-355
10. Lodderstedt G., et al. Hofmeister salts and potential therapeutic compounds accelerate in vitro fibril formation of the N-terminal domain of PABPN1 containing a disease-causing alanine extension. Biochemistry 47 (2008) 2181-2189
11. Garzon-Rodriguez W., Vega A., Sepulveda-Becerra M., Milton S., Johnson D.A., Yatsimirsky A.K., and Glabe C.G. A conformation change in the carboxyl terminus of Alzheimer's Abeta (1-40) accompanies the transition from dimer to fibril as revealed by fluorescence quenching analysis. J. Biol. Chem. 275 (2000) 22645-22649
12. Dusa A., Kaylor J., Edridge S., Bodner N., Hong D.P., and Fink A.L. Characterization of oligomers during alpha-synuclein aggregation using intrinsic tryptophan fluorescence. Biochemistry 45 (2006) 2752-2760
13. Kihara M., Chatani E., Iwata K., Yamamoto K., Matsuura T., Nakagawa A., Naiki H., and Goto Y. Conformation of amyloid fibrils of beta2-microglobulin probed by tryptophan mutagenesis. J. Biol. Chem. 281 (2006) 31061-31069
14. Schmid F.X. Spectral methods of characterizing protein conformation and conformational changes. In: Creighton T.E. (Ed). Protein Structure: A Practical Approach (1997), IRL-Press/Oxford University Press, Oxford/New York/Tokio 251-285
15. Williams A.D., Portelius E., Kheterpal I., Guo J.T., Cook K.D., Xu Y., and Wetzel R. Mapping abeta amyloid fibril secondary structure using scanning proline mutagenesis. J. Mol. Biol. 335 (2004) 833-842
16. Williams A.D., Shivaprasad S., and Wetzel R. Alanine scanning mutagenesis of Abeta(1-40) amyloid fibril stability. J. Mol. Biol. 357 (2006) 1283-1294
17. Meinhardt J., et al. Similarities in the thermodynamics and kinetics of aggregation of disease-related Abeta(1-40) peptides. Protein Sci. 16 (2007) 1214-1222
18. Thomas B., and Beal M.F. Parkinson's disease. Hum. Mol. Genet. 16 Spec. No. 2 (2007) R183-R194
19. Fredenburg R.A., Rospigliosi C., Meray R.K., Kessler J.C., Lashuel H.A., Eliezer D., and Lansbury Jr. P.T. The impact of the E46K mutation on the properties of alpha-synuclein in its monomeric and oligomeric states. Biochemistry 46 (2007) 7107-7118
20. Chou P.Y., and Fasman G.D. Conformational parameters for amino acids in helical, beta-sheet, and random coil regions calculated from proteins. Biochemistry 13 (1974) 211-222
21. Rochet J.C., Conway K.A., and Lansbury Jr. P.T. Inhibition of fibrillization and accumulation of prefibrillar oligomers in mixtures of human and mouse alpha-synuclein. Biochemistry 39 (2000) 10619-10626